Opiant Pharmaceuticals Stock Price

0.00 (0.0%)
Volume 0
Bid Price 10.00
Ask Price 41.00
News -
Day High


52 Week Range


Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Opiant Pharmaceuticals Inc OPNT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 25.22 04:00:00
Open Price Low Price High Price Close Price Prev Close
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 25.22 USD


Draw Mode:

Opiant Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 119.05M 4.72M 4.50M $ 29.63M $ 1.97M -0.46 519.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 9.60%

more financials information »

Opiant Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OPNT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week28.8329.13825.2227.2072,858-3.61-12.52%
1 Month37.0037.1525.2230.8258,309-11.78-31.84%
3 Months22.9337.711422.010130.2565,1872.299.99%
6 Months17.0637.711413.8025.7858,6258.1647.83%
1 Year9.1937.71149.0019.2672,41816.03174.43%
3 Years14.8237.71146.787815.2744,77410.4070.18%
5 Years24.5051.906.787818.8747,0400.722.94%

Opiant Pharmaceuticals Description

Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.

Your Recent History
Opiant Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.